Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Hoffman, Aaron E ^a   Zheng, Tongzhang ^a   Ba, Yue ^a   Stevens, Richard G ^b   Yi, Chun Hui ^a   Leaderer, Derek ^a   Zhu, Yong ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 AND CYCLIN DEPENDENT KINASE INHIBITOR 1A INTERACTING PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CRYPTOCHROME 2; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45ALPHA; HECT DOMAIN AND RLD5 PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 5; PHOSPHOPROTEIN PHOSPHATASE 1; PP1R15A PROTEIN; PROTEIN BCL 2; SMALL INTERFERING RNA; SUMO 1 PROTEIN; UBIQUITIN; UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CRY2 PROTEIN, HUMAN; CRYPTOCHROME; MUTAGENIC AGENT;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GENE EXPRESSION REGULATION; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ADENOCARCINOMA; BREAST TUMOR; CELL CYCLE; CIRCADIAN RHYTHM; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CIRCADIAN RHYTHM; CRYPTOCHROMES; DNA DAMAGE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MUTAGENS;

EID: 77952247107     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-110     Document Type: Article

References (28)

1. Oster H. The genetic basis of circadian behavior. Genes Brain Behav 2006, 5(Suppl 2):73-79.
2. Young MW, Kay SA. Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2001, 2(9):702-715. 10.1038/35088576, 11533719.
3. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 2001, 63:647-676. 10.1146/annurev.physiol.63.1.647, 11181971.
4. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002, 418(6901):935-941. 10.1038/nature00965, 12198538.
5. Le Minh N, Damiola F, Tronche F, Schutz G, Schibler U. Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. Embo J 2001, 20(24):7128-7136. 10.1093/emboj/20.24.7128, 125339, 11742989.
6. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417(6884):78-83. 10.1038/nature744, 11967526.
7. Duffield GE, Best JD, Meurers BH, Bittner A, Loros JJ, Dunlap JC. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol 2002, 12(7):551-557. 10.1016/S0960-9822(02)00765-0, 11937023.
8. Thresher RJ, Vitaterna MH, Miyamoto Y, Kazantsev A, Hsu DS, Petit C, Selby CP, Dawut L, Smithies O, Takahashi JS, Sancar A. Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. Science 1998, 282(5393):1490-1494. 10.1126/science.282.5393.1490, 9822380.
9. Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 2005, 25(8):3109-3116. 10.1128/MCB.25.8.3109-3116.2005, 1069621, 15798197.
10. Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 2005, 65(15):6828-6834. 10.1158/0008-5472.CAN-05-1119, 16061665.
11. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003, 302(5643):255-259. 10.1126/science.1086271, 12934012.
12. Watson JV, Chambers SH, Smith PJ. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 1987, 8(1):1-8. 10.1002/cyto.990080101, 3803091.
13. Olive PL, Banath JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res 1990, 122(1):86-94. 10.2307/3577587, 2320728.
14. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57(1):289-300.
15. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8(8):2127-2133.
16. Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 2005, 23(18):4215-4224. 10.1200/JCO.2005.05.064, 15961768.
17. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98(2):193-205. 10.1016/S0092-8674(00)81014-4, 10428031.
18. Antoch MP, Kondratov RV, Takahashi JS. Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle 2005, 4(7):901-907.
19. Xiang S, Coffelt SB, Mao L, Yuan L, Cheng Q, Hill SM. Period-2: a tumor suppressor gene in breast cancer. J Circadian Rhythms 2008, 6:4. 10.1186/1740-3391-6-4, 2365929, 18334030.
20. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 2008, 283(8):4535-4542. 10.1074/jbc.M705576200, 18086663.
21. Kondratov RV, Gorbacheva VY, Antoch MP. The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. Curr Top Dev Biol 2007, 78:173-216. full_text, 17338917.
22. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA 2009, 106(8):2841-2846. 10.1073/pnas.0813028106, 2634797,2634797, 19188586.
23. Kang TH, Reardon JT, Kemp M, Sancar A. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Natl Acad Sci USA 2009, 106(8):2864-2867. 10.1073/pnas.0812638106, 2629438,2629438, 19164551.
24. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, Takahashi JS, Sancar A. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA 1999, 96(21):12114-12119. 10.1073/pnas.96.21.12114, 18421, 10518585.
25. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434(7035):864-870. 10.1038/nature03482, 15829956.
26. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434(7035):907-913. 10.1038/nature03485, 15829965.
27. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005, 102(9):3407-3412. 10.1073/pnas.0409897102, 546637,546637, 15689397.
28. Lis CG, Grutsch JF, Wood P, You M, Rich I, Hrushesky WJ. Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther 2003, 2(2):105-111. 10.1177/1534735403002002002, 15035897.